CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-12 | Ali Asif Chief Financial Officer | Option exercise · Stock Option (right to buy) | −9,700 | 66,800 | ||
| 2025-03-05 | PATEL DINESH V PH D President and CEO | Option exercise | +24,000 | $4.21 | $101K | 564,260 |
| 2025-03-05 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −24,000 | 30,000 | ||
| 2025-02-19 | PATEL DINESH V PH D President and CEO | Sale | −5,359 | $38.18 | $205K | 540,260 |
| 2025-01-16 | MOLINA ARTURO MD Chief Medical Officer | Sale | −388 | 87,144 | ||
| 2025-01-16 | MOLINA ARTURO MD Chief Medical Officer | Sale | −3,252 | 83,892 | ||
| 2025-01-16 | Ali Asif Chief Financial Officer | Sale | −1,317 | 65,422 | ||
| 2025-01-16 | Ali Asif Chief Financial Officer | Sale | −2,601 | 62,821 | ||
| 2025-01-15 | PATEL DINESH V PH D President and CEO | Shares withheld for taxes | −12,636 | 545,619 | ||
| 2025-01-02 | Waddill William D. Director | Grant or award | +5,130 | 17,130 | ||
| 2025-01-02 | Waddill William D. Director | Grant or award · Stock Option (right to buy) | +6,584 | 6,584 | ||
| 2025-01-02 | O'Dowd Sarah A Director | Grant or award | +5,130 | 5,130 | ||
| 2025-01-02 | O'Dowd Sarah A Director | Grant or award · Stock Option (right to buy) | +6,584 | 6,584 | ||
| 2025-01-02 | Williams Lewis T Director | Grant or award | +5,130 | 5,130 | ||
| 2025-01-02 | Williams Lewis T Director | Grant or award · Stock Option (right to buy) | +6,584 | 6,584 | ||
| 2025-01-02 | SELICK HAROLD E Director | Grant or award | +5,130 | 33,126 | ||
| 2025-01-02 | SELICK HAROLD E Director | Grant or award · Stock Option (right to buy) | +6,584 | 6,584 | ||
| 2025-01-02 | PATEL DINESH V PH D President and CEO | Grant or award | +149,800 | 558,255 | ||
| 2025-01-02 | PATEL DINESH V PH D President and CEO | Grant or award · Stock Option (right to buy) | +181,472 | 181,472 | ||
| 2025-01-02 | Giraudo Bryan Director | Grant or award | +5,130 | 15,130 |
Page 9 of 29 · 580 trades